Sell Ajanta Pharma, target Rs 1075: Kunal Bothra

Independent analyst Kunal Bothra has a sell call on Ajanta Pharma Ltd. with a target price of Rs 1075. The current market price of Ajanta Pharma Ltd. is Rs 1110.9. Time period given by the analyst is Intra Day when Ajanta Pharma Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 1125.

Ajanta Pharma Ltd., incorporated in 1979, is a midcap company with a market cap of Rs 9778.48 crore.
Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 1762.69 Crore to Sales Value (96.29 % of Total Sales), Export Incentives which contributed Rs 66.17 Crore to Sales Value (3.61 % of Total Sales) and Other Operating Revenue which contributed Rs 1.59 Crore to Sales Value (0.08 % of Total Sales)for the year ending 31-Mar-2018.


For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 510.99 Crore, down -3.64 % from last quarter Sales of Rs 530.31 Crore and up 8.00 % from last year same quarter Sales of Rs 473.12 Crore Company has reported net profit after tax of Rs 105.79 Crore in latest quarter. The company’s top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar R Dalal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal. Company has B S R & Co. LLP as its auditoRs As on 30-06-2018, the company has a total of 88,015,500 shares outstanding.